NCT01929512View on ClinicalTrials.gov

Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 750mg and Rosuvastatin 20mg

PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Diabetes Mellitus
Interventions
DRUG

HCP1201 750/20mg

750mg Metformin/20mg rosuvastatin fixed dose combination tablet orally in the morning on day1 or day8.

DRUG

Metformin SR 750mg

Co-administration of Metformin 750mg and Rosuvastatin 20mg orally in the morning on day1 or day8.

DRUG

Rosuvastatin 20mg

Co-administration of Metformin 750mg and Rosuvastatin 20mg orally in the morning on day1 or day8.

Trial Locations (1)

135-710

Samsung Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT01929512 - Comparison of PK After Administration of HCP1201 and Co-administration of Metformin SR 750mg and Rosuvastatin 20mg | Biotech Hunter | Biotech Hunter